Evidence map›Paper›PMID 41761676›Full record

ArticleStem cells translational medicine2026

Corneal regenerative contribution of endogenous and grafted limbal-corneal cells in a mouse model of simple limbal-corneal epithelial transplantation.

Marcia F D Costa, Nicola Piazza, Erika Bonacci, Sissi Dolci, Francesca Ciarpella, Marzia Di Chio, Stefania Zorzin, Andrea Corsi, Alessandro Piva, Cristiano Chiamulera and 9 more

Abstract read
In one paragraph

Article in Stem cells translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marcia F D CostaLaboratory of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.ORCID 0000-0002-8541-0468
Nicola PiazzaLaboratory of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.ORCID 0009-0004-9343-9457
Erika BonacciDepartment of Engineering for Innovation Medicine, Ophthalmology Clinic, University of Verona, Verona 37134, Italy.
Sissi DolciLaboratory of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.ORCID 0000-0001-8230-8065
Francesca CiarpellaLaboratory of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.ORCID 0000-0002-9028-2982
Marzia Di ChioLaboratory of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.
Stefania ZorzinLaboratory of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.
Andrea CorsiLaboratory of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.
Alessandro PivaLaboratory of Neuropsychopharmacology, Section Pharmacology, Department Diagnostic and Public Health, University of Verona, Verona 37134, Italy.
Cristiano ChiamuleraLaboratory of Neuropsychopharmacology, Section Pharmacology, Department Diagnostic and Public Health, University of Verona, Verona 37134, Italy.
Zulkifal MalikLaboratory of Cell Metabolism and Regenerative Medicine, Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan 20054, Italy.
Riccardo EspositoLaboratory of Cell Metabolism and Regenerative Medicine, Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan 20054, Italy.
Francesco BifariLaboratory of Cell Metabolism and Regenerative Medicine, Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan 20054, Italy.ORCID 0000-0003-2028-3012
Stefano UgelSection of Immunology, Department of Medicine, University of Verona, Verona 37134, Italy.
Adriano FasoloVeneto Eye Bank Foundation, Venice 30174, Italy.
Antonella MottaDepartment of Industrial Engineering and BIOTech Research Center, University of Trento, Trento 38123, Italy.
Stefano FerrariVeneto Eye Bank Foundation, Venice 30174, Italy.
Emilio PedrottiDepartment of Surgery, Dentistry, Pediatrics and Gynecology, Ophthalmology Clinic, University of Verona, Verona 37134, Italy.
Ilaria DecimoLaboratory of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.ORCID 0000-0002-6627-1263

Funding

European Union-Next Generation EU E53D23007260006
6 · The paper itself

Abstract

Severe ocular damage, such as corneal alkali-injury, can compromise the limbal stem cell (LSC) niches, leading to LSC deficiency (LSCD) and resulting in significant vision impairment. Current insights into the wound healing process associated with simple limbal epithelial transplantation (SLET), a therapeutic intervention for LSCD, are derived solely from clinical studies, which impose methodological limitations and hinder a complete understanding of the cellular dynamics underlying SLET. For the first time, we adapted the clinical SLET procedure to a mouse model of LSCD, enabling a robust and detailed assessment of short- and long-term morphological, immunomodulatory and cell-fate outcomes in corneal regeneration. We demonstrated that simple limbal-corneal epithelial transplantation (SLCET) treatment effectively reduces corneal opacification, vascularization, and inflammation induced by alkali-injury, with persistent benefits. We used transgenic GFP-expressing mice to isolate GFP-positive limbal-corneal cells and trace their fate in the context of SLCET. Our results revealed that both endogenous and transplanted cells contribute to replenishing the depleted limbal-corneal cell population. Furthermore, we showed that the engrafted-cells retained a long-term proliferative capacity and stemness phenotype, underscoring their role in sustained corneal regeneration. Overall, our study provides a temporal and mechanistic overview of SLCET outcomes, highlighting the engrafted-cells as key players in corneal regeneration. This framework also holds a strong translational potential for enhancing SLET's efficacy and uncovering novel LSC modulators.

Indexed as

Corneal TransplantationEpithelium, CornealLimbus CorneaeRegenerationStem Cell TransplantationAnimalsDisease Models, AnimalLimbal Stem Cell DeficiencyLimbal Stem CellsMiceMice, Inbred C57BLMice, TransgenicWound Healingcornea regenerationlimbal-corneal stem cellsLSCDSLET

Identifiers

PMID41761676
PMCPMC12948936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.